Baseline body weight tertile | P-valuea | |||
---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | ||
(n = 2292) | (n = 2300) | (n = 2282) | ||
Sociodemographic data | ||||
Age years # b | 66 (7) | 65 (7) | 63 (7) | < 0.001 |
Men, n (%) | 463 (20.2) | 1293 (56.2) | 1783 (78.13) | < 0.001 |
Education level, n (%) b | < 0.001 | |||
Primary school or less | 1360 (59.3) | 1101(47.9) | 901 (39.5) | |
High school or equivalent | 566 (24.7) | 661 (28.8) | 759 (33.3) | |
University | 366 (16.0) | 538 (23.4) | 622 (27.3) | |
Civil status, n (%)b | < 0.001 | |||
Single or divorced | 302 (13.2) | 298 (13.0) | 302 (13.2) | |
Married | 1553 (67.8) | 1724 (75.0) | 1803 (79.0) | |
Widow/Widower | 437 (19.0) | 278 (12.1) | 177 (7.8) | |
Intervention group (allocation to group B) | 1118 (48.8) | 1129 (49.1) | 1159 (51.0) | 0.342 |
Lifestyle habits | ||||
Smoking habit, n (%)b | < 0.001 | |||
Never smoker | 1382 (60.3) | 958 (41.7) | 694 (30.4) | |
Former smoker | 678 (29.6) | 1043 (45.4) | 1262 (55.3) | |
Current smoker | 232 (10.1) | 299 (13.0) | 326 (14.3) | |
Study mean 17-item MedDiet score1, b# | 9 (4) | 8 (3) | 8 (4) | 0.009 |
Total physical activity, METs.min/weekb# | 1958 (2450) | 1888 (2571) | 1734 (2603) | 0.079 |
Alcohol consumption, g/d b# | 2.2 (9.6) | 5.8 (14.6) | 8.8 (21.5) | 0.098 |
Anthropometric and clinical data | ||||
Weight (kg) #b | 73.8 (7.7) | 85.6 (5.6) | 99.2 (10.3) | < 0.001 |
Height (cm) #b | 155.0(9.0) | 163.5 (11.5) | 170.2 (10.1) | < 0.001 |
BMI, (kg/m2) #b | 29.9 (3.4) | 32.0 (4.3) | 35.0 (4.8) | < 0.001 |
Waist circumference (cm) #b | 99.4 (8.4) | 107.0 (8.0) | 116.0 (10.3) | < 0.001 |
Waist-to-height ratio# b | 0.63 (0.06) | 0.65 (0.07) | 0.69 (0.08) | < 0.001 |
ABSI#b | 82.4 (6.0) | 83.1 (5.5) | 83.5 (5.4) | < 0.001 |
Obesity; BMI ≥ 30, n (%)b | 1131 (49.4) | 1730 (75.2) | 2185 (95.8) | < 0.001 |
Obesity; BMI ≥ 30, n (%) t | 989 (43.2) | 1504 (65.4) | 1993 (87.3) | < 0.001 |
Diabetes, n (%) b | 633 (27.6) | 762 (31.3) | 769 (33.7) | < 0.001 |
Hypercholesterolemia, n (%) b | 1711 (74.7) | 1624 (70.6) | 1478 (64.8) | < 0.001 |
Hypertension, n (%) b | 1901 (82.9) | 1921 (83.6) | 1936 (84.8) | 0.204 |
Total, leucocytes (× 10e9/L)# b | 6.46 (2.04) | 6.58 (2.19) | 6.79 (2.35) | < 0.001 |
Lymphocytes (× 10e9/L)# b | 2.08 (0.90) | 2.0 (0.91) | 2.0 (0.94) | 0.0105 |
Platelets (× 10e9/L)# b | 233 (73) | 222 (74) | 211 (70) | < 0.001 |
Hemoglobin (g/dL) | 14 (1.6) | 14.5 (1.9) | 14.8 (1.9) | < 0.001 |
Use of ACE inhibitors, n (%)t | 825 (36.0) | 859 (37.4) | 875 (38.3) | 0.257 |
Received at least 1 dose of vaccine, n (%)t | 1203 (52.5) | 1180 (51.3) | 1120 (49.1) | 0.065 |
COVID-19 incident cases, n (%)t | 169 (7.4) | 222 (9.7) | 262 (11.5) | < 0.001 |
Time in trial at pre-censoring visit (years) # | 5.1 (1.0) | 5.1 (1.0) | 5.1 (1.0) | 0.153 |
Body weight change (%)tc | − 2.2 (7.5) | − 2.2 (7.8) | − 2.6 (7.9) | 0.039 |
Survival time (years) # | 5.8 (1.3) | 5.8 (1.2) | 5.8 (1.3) | 0.061 |